Partnering

Today, more than 100 million people rely on Zentiva’s products and services. By 2028, our goal is to reach 1 in 5 people across Europe. We are committed to improving access to healthcare by ensuring a reliable supply of high-quality, affordable medicines for those who depend on them every day. To achieve this, we are building strong partnerships with those who share our values and our sense of responsibility.

At the core of our growth strategy is Zent2U, our dedicated business-to-business (B2B) platform. Zent2U offers a comprehensive range of services, including active pharmaceutical ingredients (APIs), contract development and manufacturing (CDMO) solutions, and the licensing of our proprietary know-how. We bring deep expertise in key therapeutic areas such as cardiology, urology, oncology, neurology, and hormone-related treatments. 

Additionally, Prague Scientific delivers end-to-end development and scientific services, supporting every stage of the pharmaceutical lifecycle - from concept to compliant product maintenance. Its expertise spans three core pillars: API and formulation R&D, manufacturing at Zentiva’s state-of-the-art, sustainable production facilities, and scientific affairs, encompassing regulatory affairs and pharmacovigilance across a broad portfolio of products. Prague Scientific also fosters innovation through its academic partnership with the PARC – the Pharmaceutical Applied Research Centre.